| pubmed-article:10785875 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10785875 | lifeskim:mentions | umls-concept:C0006938 | lld:lifeskim |
| pubmed-article:10785875 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:10785875 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:10785875 | lifeskim:mentions | umls-concept:C0140591 | lld:lifeskim |
| pubmed-article:10785875 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:10785875 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10785875 | pubmed:dateCreated | 2000-6-6 | lld:pubmed |
| pubmed-article:10785875 | pubmed:abstractText | Rilmenidine is an innovative antihypertensive agent that binds specifically to I1 imidazoline receptors. The antihypertensive efficacy of rilmenidine in treating type-2 diabetics has been demonstrated, and is associated with very good clinical and laboratory tolerance. | lld:pubmed |
| pubmed-article:10785875 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10785875 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10785875 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10785875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10785875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10785875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10785875 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10785875 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10785875 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10785875 | pubmed:issn | 1350-6277 | lld:pubmed |
| pubmed-article:10785875 | pubmed:author | pubmed-author:BauduceauBB | lld:pubmed |
| pubmed-article:10785875 | pubmed:author | pubmed-author:MayaudonHH | lld:pubmed |
| pubmed-article:10785875 | pubmed:author | pubmed-author:DupuyOO | lld:pubmed |
| pubmed-article:10785875 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10785875 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:10785875 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10785875 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10785875 | pubmed:pagination | 57-61 | lld:pubmed |
| pubmed-article:10785875 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:meshHeading | pubmed-meshheading:10785875... | lld:pubmed |
| pubmed-article:10785875 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10785875 | pubmed:articleTitle | Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril. | lld:pubmed |
| pubmed-article:10785875 | pubmed:affiliation | Service d'endocrinologie, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France. | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10785875 | pubmed:publicationType | Multicenter Study | lld:pubmed |
